Characteristics and Risk Factors Associated With Mortality in a Multicenter Spanish Cohort of Patients With COVID-19 Pneumonia

Casas Rojo, 2020, Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry, Rev Clin Esp, 220, 480, 10.1016/j.rce.2020.07.003 Pollán, 2020, Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study, Lancet, 10.1016/S0140-6736(20)31483-5 Moraga, 2020, Assessing the age- and gender-dependence of the severity and case fatality rates of COVID-19 disease in Spain, Wellcome Open Res, 5, 117, 10.12688/wellcomeopenres.15996.1 Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3 Li, 2020, Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan, J Allergy Clin Immunol, 146, 110, 10.1016/j.jaci.2020.04.006 Jordan, 2020, Covid-19: risk factors for severe disease and death, BMJ, 368 Borobia, 2020, A cohort of patients with COVID-19 in a major teaching hospital in Europe, J Clin Med, 9, 1733, 10.3390/jcm9061733 Richardson, 2020, Presenting characteristics comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area, JAMA, 323, 2052, 10.1001/jama.2020.6775 Onder, 2020, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy, JAMA, 323, 1775 Berenguer, 2020, Characteristics and predictors of death among 4,035 consecutively hospitalized patients with COVID-19 in Spain, Clin Microbiol Infect, 10.1016/j.cmi.2020.07.024 García-Basteiro, 2020, The need for an independent evaluation of the COVID-19 response in Spain, Lancet, 10.1016/S0140-6736(20)31713-X Docherty, 2020, Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study, BMJ, 369, m1985, 10.1136/bmj.m1985 Tian, 2020, Characteristics of COVID-19 infection in Beijing, J Infect, 80, 401, 10.1016/j.jinf.2020.02.018 Gebhard, 2020, Impact of sex and gender on COVID-19 outcomes in Europe, Biol Sex Differ, 11, 29, 10.1186/s13293-020-00304-9 Livingston, 2020, Coronavirus disease 2019 (COVID-19) in Italy, JAMA, 323, 10.1001/jama.2020.4344 Li, 2020, Dynamic relationship between D-dimer and COVID-19 severity, Br J Haematol, 10.1111/bjh.16811 Liang, 2020, Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China, Eur Respir J, 55, 10.1183/13993003.00562-2020 Suleyman, 2020, Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in Metropolitan Detroit, JAMA Netw Open, 3, 10.1001/jamanetworkopen.2020.12270 Gao, 2020, Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19, J Med Virol, 92, 791, 10.1002/jmv.25770 Ferrando, 2020, Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS, Intensive Care Med, 10.1007/s00134-020-06192-2 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Arentz, 2020, Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State, JAMA, 323, 1612, 10.1001/jama.2020.4326 Mehra, 2020, Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, Lancet, 395, 1820, 10.1016/S0140-6736(20)31324-6 Gautret, 2020, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents, 56, 105949, 10.1016/j.ijantimicag.2020.105949 Mahévas, 2020, Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data, BMJ, 369 Molina, 2020, No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection, Med Mal Infect, 50, 384, 10.1016/j.medmal.2020.03.006 Gautret, 2020, Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study, Travel Med Infect Dis, 34, 101663, 10.1016/j.tmaid.2020.101663 Gao, 2020, Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci Trends, 14, 72, 10.5582/bst.2020.01047 Lu, 2020, Potential therapeutic agents against COVID-19: what we know so far, J Chin Med Assoc Irvani, 2020, Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial, Trials, 21, 473, 10.1186/s13063-020-04382-3 Lan, 2020, Tocilizumab for severe COVID-19: a systematic review and meta-analysis, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2020.106103 Fadel, 2020, Early short course corticosteroids in hospitalized patients with COVID-19, Clin Infect Dis Off Publ Infect Dis Soc Am, 10.1093/cid/ciaa601 Monedero, 2021, Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study, Crit Care, 25, 2, 10.1186/s13054-020-03422-3 World Health Organization. Corticosteroids for COVID-19; 2020. https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Corticosteroids-2020.1 [accessed 1.02.21]. Ye, 2020, Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis, CMAJ Can Med Assoc J J Assoc Medicale Can, 192, E756, 10.1503/cmaj.200645 Grasselli, 2020, Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to icus of the Lombardy Region Italy, JAMA, 323, 1574, 10.1001/jama.2020.5394 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 Signes-Costa, 2020, Prevalence and 30-day mortality in hospitalized patients with Covid-19 and prior lung diseases, Arch Bronconeumol